• レポートコード:QY2112C03923 • 出版社/出版日:QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、100ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はリスペリドンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。リスペリドンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(錠剤、溶液、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・リスペリドンの世界市場概要 ・メーカー別の競争状況、市場シェア ・リスペリドンの種類別市場規模:錠剤、溶液、その他 ・リスペリドンの用途別市場規模:病院、クリニック、その他 ・北米のリスペリドン市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ) ・ヨーロッパのリスペリドン市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス) ・アジアのリスペリドン市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国) ・中南米のリスペリドン市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル) ・中東・アフリカのリスペリドン市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア) ・企業情報:Pharaonia Pharmaceuticals、Aurobindo Pharma、Wellona Pharma、Hikma Pharmaceuticals、Janssen Pharmaceuticals、Amneal Pharmaceuticals、Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. ・リスペリドンのバリューチェーン・販売チャネル分析 ・リスペリドンの世界市場動向 |
Risperdal (generic name risperidone) is an antipsychotic drug prescribed to treat schizophrenia, bipolar disorder and some behavioral problems in children with autism. It works by changing the effects of chemicals in the brain. It rebalances dopamine and serotonin to potentially improve mood, behavior and thinking.
Market Analysis and Insights: Global Risperidone Market
The global Risperidone market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Risperidone Scope and Segment
Risperidone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Risperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Tablets
Solution
Others
Segment by Application
Hospital
Clinic
Others
By Company
Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Solution
1.2.4 Others
1.3 Market by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Risperidone Sales Estimates and Forecasts 2016-2027
2.2 Global Risperidone Revenue Estimates and Forecasts 2016-2027
2.3 Global Risperidone Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Risperidone Regions by Sales
2.4.1 Global Top Risperidone Regions by Sales (2016-2021)
2.4.2 Global Top Risperidone Regions by Sales (2022-2027)
2.5 Global Top Risperidone Regions by Revenue
2.5.1 Global Top Risperidone Regions by Revenue (2016-2021)
2.5.2 Global Top Risperidone Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Risperidone Sales by Manufacturers
3.1.1 Global Top Risperidone Manufacturers by Sales (2016-2021)
3.1.2 Global Top Risperidone Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Risperidone Sales in 2020
3.2 Global Risperidone Revenue by Manufacturers
3.2.1 Global Top Risperidone Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Risperidone Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2020
3.3 Global Risperidone Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Risperidone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risperidone Sales by Type
4.1.1 Global Risperidone Historical Sales by Type (2016-2021)
4.1.2 Global Risperidone Forecasted Sales by Type (2022-2027)
4.1.3 Global Risperidone Sales Market Share by Type (2016-2027)
4.2 Global Risperidone Revenue by Type
4.2.1 Global Risperidone Historical Revenue by Type (2016-2021)
4.2.2 Global Risperidone Forecasted Revenue by Type (2022-2027)
4.2.3 Global Risperidone Revenue Market Share by Type (2016-2027)
4.3 Global Risperidone Price by Type
4.3.1 Global Risperidone Price by Type (2016-2021)
4.3.2 Global Risperidone Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Risperidone Sales by Application
5.1.1 Global Risperidone Historical Sales by Application (2016-2021)
5.1.2 Global Risperidone Forecasted Sales by Application (2022-2027)
5.1.3 Global Risperidone Sales Market Share by Application (2016-2027)
5.2 Global Risperidone Revenue by Application
5.2.1 Global Risperidone Historical Revenue by Application (2016-2021)
5.2.2 Global Risperidone Forecasted Revenue by Application (2022-2027)
5.2.3 Global Risperidone Revenue Market Share by Application (2016-2027)
5.3 Global Risperidone Price by Application
5.3.1 Global Risperidone Price by Application (2016-2021)
5.3.2 Global Risperidone Price Forecast by Application (2022-2027)
6 North America
6.1 North America Risperidone Market Size by Type
6.1.1 North America Risperidone Sales by Type (2016-2027)
6.1.2 North America Risperidone Revenue by Type (2016-2027)
6.2 North America Risperidone Market Size by Application
6.2.1 North America Risperidone Sales by Application (2016-2027)
6.2.2 North America Risperidone Revenue by Application (2016-2027)
6.3 North America Risperidone Market Size by Country
6.3.1 North America Risperidone Sales by Country (2016-2027)
6.3.2 North America Risperidone Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Risperidone Market Size by Type
7.1.1 Europe Risperidone Sales by Type (2016-2027)
7.1.2 Europe Risperidone Revenue by Type (2016-2027)
7.2 Europe Risperidone Market Size by Application
7.2.1 Europe Risperidone Sales by Application (2016-2027)
7.2.2 Europe Risperidone Revenue by Application (2016-2027)
7.3 Europe Risperidone Market Size by Country
7.3.1 Europe Risperidone Sales by Country (2016-2027)
7.3.2 Europe Risperidone Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Risperidone Market Size by Type
8.1.1 Asia Pacific Risperidone Sales by Type (2016-2027)
8.1.2 Asia Pacific Risperidone Revenue by Type (2016-2027)
8.2 Asia Pacific Risperidone Market Size by Application
8.2.1 Asia Pacific Risperidone Sales by Application (2016-2027)
8.2.2 Asia Pacific Risperidone Revenue by Application (2016-2027)
8.3 Asia Pacific Risperidone Market Size by Region
8.3.1 Asia Pacific Risperidone Sales by Region (2016-2027)
8.3.2 Asia Pacific Risperidone Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Risperidone Market Size by Type
9.1.1 Latin America Risperidone Sales by Type (2016-2027)
9.1.2 Latin America Risperidone Revenue by Type (2016-2027)
9.2 Latin America Risperidone Market Size by Application
9.2.1 Latin America Risperidone Sales by Application (2016-2027)
9.2.2 Latin America Risperidone Revenue by Application (2016-2027)
9.3 Latin America Risperidone Market Size by Country
9.3.1 Latin America Risperidone Sales by Country (2016-2027)
9.3.2 Latin America Risperidone Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Risperidone Market Size by Type
10.1.1 Middle East and Africa Risperidone Sales by Type (2016-2027)
10.1.2 Middle East and Africa Risperidone Revenue by Type (2016-2027)
10.2 Middle East and Africa Risperidone Market Size by Application
10.2.1 Middle East and Africa Risperidone Sales by Application (2016-2027)
10.2.2 Middle East and Africa Risperidone Revenue by Application (2016-2027)
10.3 Middle East and Africa Risperidone Market Size by Country
10.3.1 Middle East and Africa Risperidone Sales by Country (2016-2027)
10.3.2 Middle East and Africa Risperidone Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pharaonia Pharmaceuticals
11.1.1 Pharaonia Pharmaceuticals Corporation Information
11.1.2 Pharaonia Pharmaceuticals Overview
11.1.3 Pharaonia Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Pharaonia Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pharaonia Pharmaceuticals Recent Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Corporation Information
11.2.2 Aurobindo Pharma Overview
11.2.3 Aurobindo Pharma Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aurobindo Pharma Recent Developments
11.3 Wellona Pharma
11.3.1 Wellona Pharma Corporation Information
11.3.2 Wellona Pharma Overview
11.3.3 Wellona Pharma Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Wellona Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wellona Pharma Recent Developments
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Corporation Information
11.4.2 Hikma Pharmaceuticals Overview
11.4.3 Hikma Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Hikma Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Pharmaceuticals Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Janssen Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Pharmaceuticals Recent Developments
11.6 Amneal Pharmaceuticals
11.6.1 Amneal Pharmaceuticals Corporation Information
11.6.2 Amneal Pharmaceuticals Overview
11.6.3 Amneal Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amneal Pharmaceuticals Recent Developments
11.7 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
11.7.1 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Corporation Information
11.7.2 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Overview
11.7.3 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Risperidone Value Chain Analysis
12.2 Risperidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Production Mode & Process
12.4 Risperidone Sales and Marketing
12.4.1 Risperidone Sales Channels
12.4.2 Risperidone Distributors
12.5 Risperidone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Key Findings in The Global Risperidone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Risperidone Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Solution
Table 4. Major Manufacturers of Others
Table 5. Global Risperidone Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Risperidone Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Risperidone Sales by Region (2016-2021) & (K Units)
Table 8. Global Risperidone Sales Market Share by Region (2016-2021)
Table 9. Global Risperidone Sales by Region (2022-2027) & (K Units)
Table 10. Global Risperidone Sales Market Share by Region (2022-2027)
Table 11. Global Risperidone Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Risperidone Revenue Market Share by Region (2016-2021)
Table 13. Global Risperidone Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Risperidone Revenue Market Share by Region (2022-2027)
Table 15. Global Risperidone Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Risperidone Sales Share by Manufacturers (2016-2021)
Table 17. Global Risperidone Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Risperidone Revenue Share by Manufacturers (2016-2021)
Table 19. Risperidone Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2020)
Table 22. Risperidone Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Risperidone Product Offered
Table 24. Date of Manufacturers Enter into Risperidone Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Risperidone Sales by Type (2016-2021) & (K Units)
Table 27. Global Risperidone Sales by Type (2022-2027) & (K Units)
Table 28. Global Risperidone Sales Share by Type (2016-2021)
Table 29. Global Risperidone Sales Share by Type (2022-2027)
Table 30. Global Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Risperidone Revenue Share by Type (2016-2021)
Table 33. Global Risperidone Revenue Share by Type (2022-2027)
Table 34. Risperidone Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Risperidone Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Risperidone Sales by Application (2016-2021) & (K Units)
Table 37. Global Risperidone Sales by Application (2022-2027) & (K Units)
Table 38. Global Risperidone Sales Share by Application (2016-2021)
Table 39. Global Risperidone Sales Share by Application (2022-2027)
Table 40. Global Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Risperidone Revenue Share by Application (2016-2021)
Table 43. Global Risperidone Revenue Share by Application (2022-2027)
Table 44. Risperidone Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Risperidone Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Risperidone Sales by Type (2016-2021) & (K Units)
Table 47. North America Risperidone Sales by Type (2022-2027) & (K Units)
Table 48. North America Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Risperidone Sales by Application (2016-2021) & (K Units)
Table 51. North America Risperidone Sales by Application (2022-2027) & (K Units)
Table 52. North America Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Risperidone Sales by Country (2016-2021) & (K Units)
Table 55. North America Risperidone Sales by Country (2022-2027) & (K Units)
Table 56. North America Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Risperidone Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Risperidone Sales by Type (2016-2021) & (K Units)
Table 59. Europe Risperidone Sales by Type (2022-2027) & (K Units)
Table 60. Europe Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Risperidone Sales by Application (2016-2021) & (K Units)
Table 63. Europe Risperidone Sales by Application (2022-2027) & (K Units)
Table 64. Europe Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Risperidone Sales by Country (2016-2021) & (K Units)
Table 67. Europe Risperidone Sales by Country (2022-2027) & (K Units)
Table 68. Europe Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Risperidone Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Risperidone Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Risperidone Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Risperidone Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Risperidone Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Risperidone Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Risperidone Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Risperidone Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Risperidone Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Risperidone Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Risperidone Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Risperidone Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Risperidone Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Risperidone Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Risperidone Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Risperidone Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Risperidone Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Risperidone Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Risperidone Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Risperidone Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Risperidone Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Risperidone Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Risperidone Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Risperidone Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Risperidone Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Risperidone Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Risperidone Revenue by Country (2022-2027) & (US$ Million)
Table 106. Pharaonia Pharmaceuticals Corporation Information
Table 107. Pharaonia Pharmaceuticals Description and Major Businesses
Table 108. Pharaonia Pharmaceuticals Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Pharaonia Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pharaonia Pharmaceuticals Recent Developments
Table 111. Aurobindo Pharma Corporation Information
Table 112. Aurobindo Pharma Description and Major Businesses
Table 113. Aurobindo Pharma Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Aurobindo Pharma Recent Developments
Table 116. Wellona Pharma Corporation Information
Table 117. Wellona Pharma Description and Major Businesses
Table 118. Wellona Pharma Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Wellona Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Wellona Pharma Recent Developments
Table 121. Hikma Pharmaceuticals Corporation Information
Table 122. Hikma Pharmaceuticals Description and Major Businesses
Table 123. Hikma Pharmaceuticals Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Hikma Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Hikma Pharmaceuticals Recent Developments
Table 126. Janssen Pharmaceuticals Corporation Information
Table 127. Janssen Pharmaceuticals Description and Major Businesses
Table 128. Janssen Pharmaceuticals Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Janssen Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Janssen Pharmaceuticals Recent Developments
Table 131. Amneal Pharmaceuticals Corporation Information
Table 132. Amneal Pharmaceuticals Description and Major Businesses
Table 133. Amneal Pharmaceuticals Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Amneal Pharmaceuticals Recent Developments
Table 136. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Corporation Information
Table 137. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Description and Major Businesses
Table 138. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Risperidone Distributors List
Table 144. Risperidone Customers List
Table 145. Risperidone Market Trends
Table 146. Risperidone Market Drivers
Table 147. Risperidone Market Challenges
Table 148. Risperidone Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Solution Product Picture
Figure 5. Others Product Picture
Figure 6. Global Risperidone Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Risperidone Report Years Considered
Figure 11. Global Risperidone Sales 2016-2027 (K Units)
Figure 12. Global Risperidone Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Risperidone Revenue 2016-2027 (US$ Million)
Figure 14. Global Risperidone Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Risperidone Sales Market Share by Region (2016-2021)
Figure 16. Global Risperidone Sales Market Share by Region (2022-2027)
Figure 17. North America Risperidone Sales YoY (2016-2027) & (K Units)
Figure 18. North America Risperidone Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Risperidone Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Risperidone Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Risperidone Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Risperidone Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Risperidone Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Risperidone Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Risperidone Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Risperidone Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Risperidone Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Risperidone Revenue in 2020
Figure 29. Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Risperidone Sales Market Share by Type (2016-2027)
Figure 31. Global Risperidone Revenue Market Share by Type (2016-2027)
Figure 32. Global Risperidone Sales Market Share by Application (2016-2027)
Figure 33. Global Risperidone Revenue Market Share by Application (2016-2027)
Figure 34. North America Risperidone Sales Market Share by Type (2016-2027)
Figure 35. North America Risperidone Revenue Market Share by Type (2016-2027)
Figure 36. North America Risperidone Sales Market Share by Application (2016-2027)
Figure 37. North America Risperidone Revenue Market Share by Application (2016-2027)
Figure 38. North America Risperidone Sales Share by Country (2016-2027)
Figure 39. North America Risperidone Revenue Share by Country (2016-2027)
Figure 40. United States Risperidone Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Risperidone Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Risperidone Sales Market Share by Type (2016-2027)
Figure 43. Europe Risperidone Revenue Market Share by Type (2016-2027)
Figure 44. Europe Risperidone Sales Market Share by Application (2016-2027)
Figure 45. Europe Risperidone Revenue Market Share by Application (2016-2027)
Figure 46. Europe Risperidone Sales Share by Country (2016-2027)
Figure 47. Europe Risperidone Revenue Share by Country (2016-2027)
Figure 48. Germany Risperidone Revenue (2016-2027) & (US$ Million)
Figure 49. France Risperidone Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Risperidone Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Risperidone Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Risperidone Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Risperidone Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Risperidone Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Risperidone Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Risperidone Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Risperidone Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Risperidone Revenue Share by Region (2016-2027)
Figure 59. China Risperidone Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Risperidone Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Risperidone Revenue (2016-2027) & (US$ Million)
Figure 62. India Risperidone Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Risperidone Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Risperidone Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Risperidone Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Risperidone Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Risperidone Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Risperidone Sales Market Share by Type (2016-2027)
Figure 69. Latin America Risperidone Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Risperidone Sales Market Share by Application (2016-2027)
Figure 71. Latin America Risperidone Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Risperidone Sales Share by Country (2016-2027)
Figure 73. Latin America Risperidone Revenue Share by Country (2016-2027)
Figure 74. Mexico Risperidone Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Risperidone Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Risperidone Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Risperidone Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Risperidone Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Risperidone Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Risperidone Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Risperidone Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Risperidone Revenue Share by Country (2016-2027)
Figure 83. Turkey Risperidone Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Risperidone Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Risperidone Revenue (2016-2027) & (US$ Million)
Figure 86. Risperidone Value Chain
Figure 87. Risperidone Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed